Omri Gottesman is the CEO of Empirico Inc., a biotechnology company focused on the discovery and development of novel medicines. Prior to their current role, Omri held positions at Regeneron Pharmaceuticals, Inc. as the Head of Clinical Informatics and at NHS England as a Medical Doctor focusing on Ambulatory Care and Acute Medicine. Omri also served as an Assistant Professor of Medicine at Icahn School of Medicine at Mount Sinai and completed a Fellowship in Personalized Medicine. Omri earned a Doctor of Medicine degree from UCL and a BSc in Pharmacology.
2018 - present